Registered number
14696691
ALIYAH PHARMS LTD
Filleted Accounts
31 March 2024
ALIYAH PHARMS LTD
Registered number: 14696691
Balance Sheet
as at 31 March 2024
Notes 2024
£
Fixed assets
Tangible assets 3 1,080
Current assets
Cash at bank and in hand 10,798
Creditors: amounts falling due within one year 4 (8,343)
Net current assets 2,455
Total assets less current liabilities 3,535
Creditors: amounts falling due after more than one year 5 (2,180)
Net assets 1,355
Capital and reserves
Called up share capital 100
Profit and loss account 1,255
Shareholders' funds 1,355
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
ALIYAH AUYUB SIDAT
Director
Approved by the board on 11 April 2024
ALIYAH PHARMS LTD
Notes to the Accounts
for the year ended 31 March 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery over 10 years
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 Employees 2024
Number
Average number of persons employed by the company 1
3 Tangible fixed assets
Plant and machinery etc
£
Cost
Additions 1,200
At 31 March 2024 1,200
Depreciation
Charge for the year 120
At 31 March 2024 120
Net book value
At 31 March 2024 1,080
4 Creditors: amounts falling due within one year 2024
£
Taxation and social security costs 1,214
Other creditors 7,129
8,343
5 Creditors: amounts falling due after one year 2024
£
Directors Loan 2,180
6 Controlling party
The company is under the ultimate control of the director by virtue of them owning the fully issued share capital.
7 Other information
ALIYAH PHARMS LTD is a private company limited by shares and incorporated in England. Its registered office is:
39 HARTLEY STREET
DEWSBURY
UNITED KINGDOM
WF13 2BQ
ALIYAH PHARMS LTD 14696691 false 2023-04-01 2024-03-31 2024-03-31 VT Final Accounts April 2022 ALIYAH AUYUB SIDAT No description of principal activity 14696691 2023-04-01 2024-03-31 14696691 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 14696691 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 14696691 bus:Director40 2023-04-01 2024-03-31 14696691 1 2023-04-01 2024-03-31 14696691 2 2023-04-01 2024-03-31 14696691 countries:England 2023-04-01 2024-03-31 14696691 bus:FRS102 2023-04-01 2024-03-31 14696691 bus:FullAccounts 2023-04-01 2024-03-31 14696691 2024-03-31 14696691 core:WithinOneYear 2024-03-31 14696691 core:AfterOneYear 2024-03-31 14696691 core:ShareCapital 2024-03-31 14696691 core:RetainedEarningsAccumulatedLosses 2024-03-31 14696691 2023-03-31 iso4217:GBP xbrli:pure